Figure 5C shows that the Open Targets report highlighting the protective role that QPCT inhibitors have played in hypertension studies [42,43]. N-acetylhistamine and glutamine t-butyl ester were both developed as inhibitors of human glutaminyl cyclase, as illustrated in Figure 5D [44,45]. The gene discussed is QPCT; the disease is hypertensive disorder.